Memphis, TN – According to filings with the U.S. Securities and Exchange Commission, Hapten Sciences is raising $1,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Raymond Hage played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hapten Sciences

Hapten Sciences is a privately held biopharmaceutical company based in Memphis, Tennessee. The company’s mission is to identify and efficiently develop novel, early-stage products that will significantly contribute to the health and well being of people around the world.

To learn more about Hapten Sciences, visit http://www.haptensciences.com/

Contact:
Raymond Hage, Chief Executive Officer
901-747-3946
https://www.linkedin.com/in/ray-hage-b149977/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved